Interestingly, some genes that have been described to suppress the high body fat phenotype, hepatic steatosis, and potentially also myosteatosis are strongly downregulated in tumors because they are putative tumor-suppressor genes, such as SFRP1, SFRP5, and DKK3 [42]. This evidence concerns the gene SFRP1 and neoplasm.